Javier Manero

676 total citations
9 papers, 121 citations indexed

About

Javier Manero is a scholar working on Rheumatology, Immunology and Pharmacology. According to data from OpenAlex, Javier Manero has authored 9 papers receiving a total of 121 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 5 papers in Immunology and 2 papers in Pharmacology. Recurrent topics in Javier Manero's work include Rheumatoid Arthritis Research and Therapies (7 papers), Spondyloarthritis Studies and Treatments (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). Javier Manero is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Spondyloarthritis Studies and Treatments (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). Javier Manero collaborates with scholars based in Spain, United States and Switzerland. Javier Manero's co-authors include Luis Valmor Portela, Eduardo Henrik Aubert, Calixto Machado, L. Galán, Miguel A. Álvarez, Federico Díaz‐González, M.V. Hernández, Javier del Pino‐Montes, Eduardo Cuende and Juan J. Gómez‐Reino and has published in prestigious journals such as Medicine, European Journal of Clinical Investigation and Rheumatology International.

In The Last Decade

Javier Manero

8 papers receiving 121 citations

Peers

Javier Manero

RHEUM

CN

IMMUN

HEMAT

EPIDE

Allan Perel United States

Marzia Fronza Italy

Mohsen Farvardin Iran

Cinzia Caserta Italy

Cécile Dulau France

Ezgi Yılmaz Türkiye

Sushma Yalamanchili United States

Youssef Sidhom Tunisia

Leonardo Sinisi Italy

David Reyes‐Leiva Spain

Allan Perel United States

Javier Manero

36 ×0.6

RHEUM

3 ×0.1

CN

19 ×0.7

IMMUN

11 ×0.4

HEMAT

15 ×0.8

EPIDE

Citations per year, relative to Javier Manero Javier Manero (= 1×) peers Allan Perel

Countries citing papers authored by Javier Manero

Since Specialization

Citations

This map shows the geographic impact of Javier Manero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Manero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Manero more than expected).

Fields of papers citing papers by Javier Manero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Manero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Manero. The network helps show where Javier Manero may publish in the future.

Co-authorship network of co-authors of Javier Manero

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Manero. A scholar is included among the top collaborators of Javier Manero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Manero. Javier Manero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

López‐Medina, Clementina, Fernando Sánchez‐Alonso, Vega Jovaní, et al.. (2025). One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry. Reumatología Clínica. 21(5). 501872–501872.

2.

Sánchez‐Piedra, Carlos, Paloma Vela, Manuel José Moreno Ramos, et al.. (2023). Real‐world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis. European Journal of Clinical Investigation. 54(2). e14095–e14095. 2 indexed citations

3.

Pombo‐Suárez, Manuel, Daniel Seoane‐Mato, Federico Díaz‐González, et al.. (2022). Long‐term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis. Musculoskeletal Care. 21(1). 189–197. 5 indexed citations

4.

Sancho, Juan José Alegre, Xavier Juanola, José Manuel Rodríguez Heredia, et al.. (2021). Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis. Medicine. 100(13). e25223–e25223. 8 indexed citations

5.

Sánchez‐Piedra, Carlos, Javier Manero, Rosa Roselló, et al.. (2019). Objectives and methodology of BIOBADASER phase III. Reumatología Clínica (English Edition). 15(4). 229–236. 3 indexed citations

6.

Hernández, M.V., Carlos Sánchez‐Piedra, Eduardo Cuende, et al.. (2018). Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry. Rheumatology International. 39(3). 509–515. 28 indexed citations

7.

Sánchez‐Piedra, Carlos, M.V. Hernández, Javier Manero, et al.. (2017). Objetivos y metodología de la fase iii de BIOBADASER. Reumatología Clínica. 15(4). 229–236. 19 indexed citations

8.

Nolla, Joan M., et al.. (2017). An estimate of the cost of administering intravenous biological agents in Spanish day hospitals. Therapeutics and Clinical Risk Management. Volume 13. 325–334. 3 indexed citations

9.

Machado, Calixto, L. Galán, Eduardo Henrik Aubert, et al.. (2007). QEEG Prognostic Value in Acute Stroke. Clinical EEG and Neuroscience. 38(3). 155–160. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact